Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Register to Attend the Weathering The Storm: Leadership In Times of Uncertainty and Upheaval Webinar

Please join Pharma Intelligence and our panel of biopharma and med tech leaders as they discuss their experiences of leading through times of uncertainty and upheaval. They will explore different approaches to unexpected events, such as the COVID-19 pandemic, and discuss the challenges of major business procedures like M&A integration and managing a change in pipeline strategy.

Session key topics include:

  • Communicating change and crisis management
  • Balancing new and old thinking across teams
  • Integrating teams after M&A or during a partnership/ Maintaining the mission


Mark Reisenauer
President, Astellas Pharma

Mark is responsible for the operations of Astellas Pharma across the U.S. He was recently Senior Leader of Astellas’ Oncology business unit and yielded the fastest-growing Oncology franchise in Astellas’ US portfolio. He was instrumental in bringing many new oncology treatments to patients, including XTANDI® (enzalutamide), XOSPATA® (gilteritinib) and PADCEVTM (enfortumab vedotin-ejfv). All three products have become standards of care in their approved indications.

Pamela Stephenson
Chief Commercial Officer, Albireo

Pamela has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. Before joining Albireo, she served as Vice President, Global Market Access and Value, at Vertex Pharmaceuticals, where she led the global market access and pricing strategy for current and future products. Earlier in her tenure at Vertex, she led marketing and sales activities for the company’s hepatitis C and cystic fibrosis lines of business, and oversaw the U.S. launches of Incivek®️ (telaprevir) and Orkambi®️(lumacaftor/ivacaftor). Prior to Vertex, Pamela spent 10 years at Pfizer in marketing roles of increasing responsibility for brands such as Viagra®️ (sildenafil citrate), Lyrica®️ (pregabalin), and Aromasin®️ (exemestane). She holds a bachelor’s degree from Brown University and received her master’s degree in public health from Boston University School of Public Health.

Semi Trotto
General Manager, Thrive, An Exact Sciences Company

Semi’s background includes more than 20 years of experience in human resources, focusing on talent management, talent acquisition, leading change and transformation, and executive and team coaching and development.              

Catherine Owen
Senior Vice President, Major Markets Bristol Myers Squibb

Catherine oversees commercialization operations in 19 key markets including Japan, Canada and Europe, covering the company’s portfolio of innovative prescription medicines in oncology, hematology, cardiovascular, and immunology.

Anthony Higham
President, BTG Specialty Pharmaceuticals

Anthony is an experienced pharmaceutical professional with over 30 years’ experience in senior roles at both big and small pharmaceutical companies.  For the past 5 years he has been President of BTG Specialty Pharmaceuticals which was recently divested by Boston Scientific and acquired by SERB, a private equity-backed European specialty pharmaceuticals company. Anthony was with GSK and predecessor SmithKline Beecham for over 20 years in various senior global roles in manufacturing, supply chain and other technical disciplines.  He joined the leadership team of FTSE-listed pharmaceutical and medical device company BTG plc in 2011 as Head of Manufacturing and Supply, later being appointed to also head the BTG Specialty Pharmaceutical division.  Anthony has direct experience of M&A activity ranging from due diligence through to business integration, and is currently helping to manage the integration of BTG Specialty Pharmaceuticals with SERB.

Complete the form to register your free place!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies